slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 87,781-87,810
Pages 3,683
Rows per page 30
Component
87,781-87,810 of 110,471
07
The slide uses a numbered list format to present core investment principles.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
10
The slide uses a numbered list format to present macro-economic observations.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
16
The slide uses a dual-axis chart to show the divergence between total bond supply and market-making capacity.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
19
The slide uses a flow diagram to show how Apollo/Athene and 3rd-party investors converge on specific investment mechanisms.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
24
The chart shows a clear upward trajectory from $252M in 2020 to a projected ~$500M in 2026E.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
34
Includes governance principles and leadership team statistics.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
35
The slide acts as a navigation hub for team-related content.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
03
Standard legal disclosure slide often found at the end of investor presentations or press releases.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
11
Includes footnotes regarding specific adjustments to equity management fees and non-compensation expenses.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
12
The slide uses stacked bar charts to visualize AUM growth and composition across three categories.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
13
The chart uses stacked bars to distinguish between Asset Management and Retirement Services, with specific callouts for 'inorganic' inflows.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
14
Includes retrospective adjustments for LDTI accounting standards.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
15
Includes detailed footnotes explaining the composition of funding agreements and the normalization methodology for SRE.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
16
Includes both actual and normalized net spread bridge charts.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
19
The slide uses three donut charts to visualize the composition of AUM and Dry Powder.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
21
Includes footnotes regarding consolidation exclusions and specific financial definitions.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
25
Contains detailed footnotes explaining the methodology for calculating outflows and flows.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Beat · Financials1 hit
36
Standard financial disclosure slide defining key performance indicators.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
38
This is a continuation of a definitions slide, listing technical terms alphabetically.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
39
This is a standard disclosure/glossary slide found in financial reporting decks.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
40
This is a standard financial disclosure slide found in investor presentations.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations 1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Logic Chain1 hit
09
The slide highlights the mechanism of action and key clinical/preclinical benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Logic Chain1 hit
10
The slide outlines the study structure for a clinical trial, categorizing cohorts by dosage and patient status (HBV DNA +/-).Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
11
Data table includes standard error (SE) values for each mean. Footnote provides specific study parameters.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
12
The slide displays longitudinal data for cohorts E, F, I, J, G, and K, with specific callouts for individual patient outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
13
The slide displays 8 individual patient charts tracking three biomarkers over 64 weeks. Two patients (53 and 58) show NA retreatment periods.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
14
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
15
The slide uses a bulleted list to present clinical safety findings.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
18
The slide outlines two distinct study arms involving AB-729, VTP-300, and Nivolumab, with a primary focus on safety and reactogenicity.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit